[HTML][HTML] Biomarkers in cancer detection, diagnosis, and prognosis

S Das, MK Dey, R Devireddy, MR Gartia - Sensors, 2023‏ - mdpi.com
Biomarkers are vital in healthcare as they provide valuable insights into disease diagnosis,
prognosis, treatment response, and personalized medicine. They serve as objective …

Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future

H Van Poppel, T Albreht, P Basu, R Hogenhout… - Nature Reviews …, 2022‏ - nature.com
In the pre-PSA-detection era, a large proportion of men were diagnosed with metastatic
prostate cancer and died of the disease; after the introduction of the serum PSA test …

Alzheimer disease as a clinical-biological construct—an International Working Group recommendation

B Dubois, N Villain, L Schneider, N Fox… - JAMA …, 2024‏ - jamanetwork.com
Importance Since 2018, a movement has emerged to define Alzheimer disease (AD) as a
purely biological entity based on biomarker findings. The recent revision of the Alzheimer's …

Recent global patterns in prostate cancer incidence and mortality rates

MBB Culp, I Soerjomataram, JA Efstathiou, F Bray… - European urology, 2020‏ - Elsevier
Context Previous studies have reported significant variation in prostate cancer rates and
trends mainly due to differences in detection practices, availability of treatment, and …

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

F Bray, J Ferlay, I Soerjomataram… - CA: a cancer journal …, 2018‏ - Wiley Online Library
This article provides a status report on the global burden of cancer worldwide using the
GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International …

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

H Sung, J Ferlay, RL Siegel… - CA: a cancer journal …, 2021‏ - Wiley Online Library
This article provides an update on the global cancer burden using the GLOBOCAN 2020
estimates of cancer incidence and mortality produced by the International Agency for …

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

F Bray, M Laversanne, H Sung, J Ferlay… - CA: a cancer journal …, 2024‏ - Wiley Online Library
This article presents global cancer statistics by world region for the year 2022 based on
updated estimates from the International Agency for Research on Cancer (IARC). There …

Underlying features of prostate cancer—statistics, risk factors, and emerging methods for its diagnosis

CV Berenguer, F Pereira, JS Câmara, JAM Pereira - Current Oncology, 2023‏ - mdpi.com
Prostate cancer (PCa) is the most frequently occurring type of malignant tumor and a leading
cause of oncological death in men. PCa is very heterogeneous in terms of grade …

Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis

D Ilic, M Djulbegovic, JH Jung, EC Hwang, Q Zhou… - bmj, 2018‏ - bmj.com
Objective To investigate the efficacy and safety of prostate-specific antigen (PSA) testing to
screen for prostate cancer. Design Systematic review and meta-analysis. Data sources …

Genetically adjusted PSA levels for prostate cancer screening

L Kachuri, TJ Hoffmann, Y Jiang, SI Berndt… - Nature medicine, 2023‏ - nature.com
Prostate-specific antigen (PSA) screening for prostate cancer remains controversial because
it increases overdiagnosis and overtreatment of clinically insignificant tumors. Accounting for …